13 July 2015
ASX RELEASE Publication of Research NoteImugene Limited
ACN 009 179 551
Suite 1, 1233 High Street
Armadale VIC 3142
Imugene Limited (ASX:IMU) is pleased to advise that a new Research Note compiled by Edison Investment Research titled "Imugene -‐ HER-‐Vaxx antibodies outperform Herceptin" is now available from the company.
To view the Research Note, please follow the link below or copy and paste the link to your web browser:
http://www.imugene.com/investor-center/analyst-coverage
IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com
distributed by |